228 results on '"Priceman, Saul J."'
Search Results
2. Nonsignaling extracellular spacer regulates tumor antigen selectivity of CAR T cells
3. Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting
4. Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy
5. Dexamethasone potentiates chimeric antigen receptor T cell persistence and function by enhancing IL-7Rα expression
6. Biology and status of chimeric antigen receptor-engineered T cell therapy
7. Contributors
8. Enhanced intratumoural activity of CAR T cells engineered to produce immunomodulators under photothermal control
9. CAR T Cell Therapy Progress and Challenges for Solid Tumors
10. Precision Medicine-Enabled Cancer Immunotherapy
11. Author response: Regulation of nuclear transcription by mitochondrial RNA in endothelial cells
12. Hyperthermic Intraperitoneal Chemotherapy–Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian Cancer
13. CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy
14. Pten Null Prostate Epithelium Promotes Localized Myeloid-Derived Suppressor Cell Expansion and Immune Suppression during Tumor Initiation and Progression
15. Using Oncolytic Virus to Retask CD19-Chimeric Antigen Receptor T Cells for Treatment of Pancreatic Cancer: Toward a Universal Chimeric Antigen Receptor T-Cell Strategy for Solid Tumor.
16. Regulation of nuclear transcription by mitochondrial RNA in endothelial cells.
17. Precision Medicine-Enabled Cancer Immunotherapy
18. Data from The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma
19. Abstract 1792: Engineering TAG72-CAR T cells as a therapeutic strategy in the hen - a spontaneous, preclinical model for ovarian cancer
20. Abstract 4104: Development of adoptive T-cell therapies to target heterogeneity of mCRPC
21. Abstract 4090: Regional administration of IL-12 endowed CAR T cells effectively targets systemic disease
22. Supplementary Figures from The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma
23. Figure S1, Figure S2, Figure S3, Figure S4, Figure S5, Figure S6 from Sphingosine-1-Phosphate Receptor-1 Promotes Environment-Mediated and Acquired Chemoresistance
24. Data from STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis
25. Data from Sphingosine-1-Phosphate Receptor-1 Promotes Environment-Mediated and Acquired Chemoresistance
26. Supplementary Figures 1 - 6 from STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis
27. Supplemental figure legends from Sphingosine-1-Phosphate Receptor-1 Promotes Environment-Mediated and Acquired Chemoresistance
28. Figure S1 from Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity
29. Figure S1, Figure S2, Figure S3, Figure S4 from Regional Delivery of Chimeric Antigen Receptor–Engineered T Cells Effectively Targets HER2+ Breast Cancer Metastasis to the Brain
30. Supplementary Materials and Methods from Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer
31. Supplemental Figure 6 from CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy
32. Data from CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy
33. Supplementary Figures 1-5 from The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer
34. Supplemental Figure 4 from CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy
35. Supplemental Figure 2 from CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy
36. Supplemental Figure Legends from CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy
37. Supplemental Figure 3 from CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy
38. Supplemental Figure 1 from CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy
39. Data from Suppression of Prostate Cancer Nodal and Systemic Metastasis by Blockade of the Lymphangiogenic Axis
40. Supplementary Figure 1 from Suppression of Prostate Cancer Nodal and Systemic Metastasis by Blockade of the Lymphangiogenic Axis
41. Supplemental Figure 5 from CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy
42. Data from The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer
43. Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting
44. Regulation of Nuclear Transcription by Mitochondrial RNA
45. STAT3 and Src Signaling in Melanoma
46. Functional Molecular Imaging of Prostate Cancer Lymph Node Metastases: Adenovirus-Mediated Lymph Node Detection
47. Advancing together and moving forward: Combination gene and cellular immunotherapies
48. PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages
49. Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell therapy
50. Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.